Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The peptide-based vaccine induces a t cell-dependent response
Both companies have been selected for stand-by production by German government
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
The expansion positions Cambrex with the largest and most advanced API facility in the United States
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Subscribe To Our Newsletter & Stay Updated
